Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin

Myung Cho, Ryszard Jedrychowski, Bruce Hammock, Alan Buckpitt

Research output: Contribution to journalArticle

Abstract

Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin. Cho, M., Jedrychowski, R., Hammock, B., and Buckpitt, A. (1994). Fundam. Appl. Toxicol. 22, 26-33. Earlier work has shown that the murine Clara cell cytotoxicant, naphthalene, is metabolized to reactive metabolites which deplete glutathione or, in the absence of sufficient glutathione, become bound covalently to tissue macromolecules. Correlations between bound metabolite levels in the lung with injury suggests an association between reactive metabolite binding and toxicity. In this study we examine the formation of covalent naphthalene adducts with hemoglobin and albumin in mice to determine whether these serve as useful indices of exposure and metabolism for a chemical which shows a glutathione threshold. Covalent binding of radioactivity from [3H]naphthalene to both albumin and hemoglobin was dose dependent and a glutathione threshold was observed. At early times after naphthalene administration, the formation of albumin adducts was 10- to 30-fold higher than that of hemoglobin adducts. Hemoglobin and albumin adduct levels decreased by apparent first-order processes with half-lives of 11.5 and 1.8 days, respectively. These half-lives are consistent with the turnover of these blood proteins in the mouse. Pretreatment with buthionine sulfoximine resulted in higher levels of albumin adduct but in no alteration of hemoglobin adduct levels in comparison with control. In contrast, diethylmaleate pretreatment increased the level of hemoglobin adduct but not albumin adduct. The antibody to naphthalene mercapturates recognized the hemoglobin adduct(s) but not the albumin adduct(s). Comparison of the data from ELISA (standardized using hydroxymercaptodihydronaphthalene) and radiochemical analysis yielded curves with identical slopes; the absolute levels of adduct found by ELISA were approximately half those measured with radiochemical techniques. These studies indicate that high levels of reactive naphthalene metabolites are bound to hemoglobin and albumin at doses above the glutathione threshold. Although hemoglobin adduct levels can be monitored sensitively with ELISA, the presence of the glutathione threshold suggests that monitoring exposed populations may not provide a useful measure of exposure at environmentally relevant exposure levels.

Original languageEnglish (US)
Pages (from-to)26-33
Number of pages8
JournalFundamental and Applied Toxicology
Volume22
Issue number1
DOIs
StatePublished - Jan 1994

Fingerprint

Metabolites
Albumins
Hemoglobins
Glutathione
diethyl maleate
Enzyme-Linked Immunosorbent Assay
naphthalene
Buthionine Sulfoximine
Radioactivity
Lung Injury
Macromolecules
Metabolism
Toxicity
Blood Proteins
Tissue
Antibodies
Monitoring

ASJC Scopus subject areas

  • Toxicology

Cite this

Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin. / Cho, Myung; Jedrychowski, Ryszard; Hammock, Bruce; Buckpitt, Alan.

In: Fundamental and Applied Toxicology, Vol. 22, No. 1, 01.1994, p. 26-33.

Research output: Contribution to journalArticle

Cho, Myung ; Jedrychowski, Ryszard ; Hammock, Bruce ; Buckpitt, Alan. / Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin. In: Fundamental and Applied Toxicology. 1994 ; Vol. 22, No. 1. pp. 26-33.
@article{e95f09320bdc4850830d8f4be6f5b2f9,
title = "Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin",
abstract = "Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin. Cho, M., Jedrychowski, R., Hammock, B., and Buckpitt, A. (1994). Fundam. Appl. Toxicol. 22, 26-33. Earlier work has shown that the murine Clara cell cytotoxicant, naphthalene, is metabolized to reactive metabolites which deplete glutathione or, in the absence of sufficient glutathione, become bound covalently to tissue macromolecules. Correlations between bound metabolite levels in the lung with injury suggests an association between reactive metabolite binding and toxicity. In this study we examine the formation of covalent naphthalene adducts with hemoglobin and albumin in mice to determine whether these serve as useful indices of exposure and metabolism for a chemical which shows a glutathione threshold. Covalent binding of radioactivity from [3H]naphthalene to both albumin and hemoglobin was dose dependent and a glutathione threshold was observed. At early times after naphthalene administration, the formation of albumin adducts was 10- to 30-fold higher than that of hemoglobin adducts. Hemoglobin and albumin adduct levels decreased by apparent first-order processes with half-lives of 11.5 and 1.8 days, respectively. These half-lives are consistent with the turnover of these blood proteins in the mouse. Pretreatment with buthionine sulfoximine resulted in higher levels of albumin adduct but in no alteration of hemoglobin adduct levels in comparison with control. In contrast, diethylmaleate pretreatment increased the level of hemoglobin adduct but not albumin adduct. The antibody to naphthalene mercapturates recognized the hemoglobin adduct(s) but not the albumin adduct(s). Comparison of the data from ELISA (standardized using hydroxymercaptodihydronaphthalene) and radiochemical analysis yielded curves with identical slopes; the absolute levels of adduct found by ELISA were approximately half those measured with radiochemical techniques. These studies indicate that high levels of reactive naphthalene metabolites are bound to hemoglobin and albumin at doses above the glutathione threshold. Although hemoglobin adduct levels can be monitored sensitively with ELISA, the presence of the glutathione threshold suggests that monitoring exposed populations may not provide a useful measure of exposure at environmentally relevant exposure levels.",
author = "Myung Cho and Ryszard Jedrychowski and Bruce Hammock and Alan Buckpitt",
year = "1994",
month = "1",
doi = "10.1006/faat.1994.1004",
language = "English (US)",
volume = "22",
pages = "26--33",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin

AU - Cho, Myung

AU - Jedrychowski, Ryszard

AU - Hammock, Bruce

AU - Buckpitt, Alan

PY - 1994/1

Y1 - 1994/1

N2 - Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin. Cho, M., Jedrychowski, R., Hammock, B., and Buckpitt, A. (1994). Fundam. Appl. Toxicol. 22, 26-33. Earlier work has shown that the murine Clara cell cytotoxicant, naphthalene, is metabolized to reactive metabolites which deplete glutathione or, in the absence of sufficient glutathione, become bound covalently to tissue macromolecules. Correlations between bound metabolite levels in the lung with injury suggests an association between reactive metabolite binding and toxicity. In this study we examine the formation of covalent naphthalene adducts with hemoglobin and albumin in mice to determine whether these serve as useful indices of exposure and metabolism for a chemical which shows a glutathione threshold. Covalent binding of radioactivity from [3H]naphthalene to both albumin and hemoglobin was dose dependent and a glutathione threshold was observed. At early times after naphthalene administration, the formation of albumin adducts was 10- to 30-fold higher than that of hemoglobin adducts. Hemoglobin and albumin adduct levels decreased by apparent first-order processes with half-lives of 11.5 and 1.8 days, respectively. These half-lives are consistent with the turnover of these blood proteins in the mouse. Pretreatment with buthionine sulfoximine resulted in higher levels of albumin adduct but in no alteration of hemoglobin adduct levels in comparison with control. In contrast, diethylmaleate pretreatment increased the level of hemoglobin adduct but not albumin adduct. The antibody to naphthalene mercapturates recognized the hemoglobin adduct(s) but not the albumin adduct(s). Comparison of the data from ELISA (standardized using hydroxymercaptodihydronaphthalene) and radiochemical analysis yielded curves with identical slopes; the absolute levels of adduct found by ELISA were approximately half those measured with radiochemical techniques. These studies indicate that high levels of reactive naphthalene metabolites are bound to hemoglobin and albumin at doses above the glutathione threshold. Although hemoglobin adduct levels can be monitored sensitively with ELISA, the presence of the glutathione threshold suggests that monitoring exposed populations may not provide a useful measure of exposure at environmentally relevant exposure levels.

AB - Reactive Naphthalene Metabolite Binding to Hemoglobin and Albumin. Cho, M., Jedrychowski, R., Hammock, B., and Buckpitt, A. (1994). Fundam. Appl. Toxicol. 22, 26-33. Earlier work has shown that the murine Clara cell cytotoxicant, naphthalene, is metabolized to reactive metabolites which deplete glutathione or, in the absence of sufficient glutathione, become bound covalently to tissue macromolecules. Correlations between bound metabolite levels in the lung with injury suggests an association between reactive metabolite binding and toxicity. In this study we examine the formation of covalent naphthalene adducts with hemoglobin and albumin in mice to determine whether these serve as useful indices of exposure and metabolism for a chemical which shows a glutathione threshold. Covalent binding of radioactivity from [3H]naphthalene to both albumin and hemoglobin was dose dependent and a glutathione threshold was observed. At early times after naphthalene administration, the formation of albumin adducts was 10- to 30-fold higher than that of hemoglobin adducts. Hemoglobin and albumin adduct levels decreased by apparent first-order processes with half-lives of 11.5 and 1.8 days, respectively. These half-lives are consistent with the turnover of these blood proteins in the mouse. Pretreatment with buthionine sulfoximine resulted in higher levels of albumin adduct but in no alteration of hemoglobin adduct levels in comparison with control. In contrast, diethylmaleate pretreatment increased the level of hemoglobin adduct but not albumin adduct. The antibody to naphthalene mercapturates recognized the hemoglobin adduct(s) but not the albumin adduct(s). Comparison of the data from ELISA (standardized using hydroxymercaptodihydronaphthalene) and radiochemical analysis yielded curves with identical slopes; the absolute levels of adduct found by ELISA were approximately half those measured with radiochemical techniques. These studies indicate that high levels of reactive naphthalene metabolites are bound to hemoglobin and albumin at doses above the glutathione threshold. Although hemoglobin adduct levels can be monitored sensitively with ELISA, the presence of the glutathione threshold suggests that monitoring exposed populations may not provide a useful measure of exposure at environmentally relevant exposure levels.

UR - http://www.scopus.com/inward/record.url?scp=0028265687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028265687&partnerID=8YFLogxK

U2 - 10.1006/faat.1994.1004

DO - 10.1006/faat.1994.1004

M3 - Article

C2 - 8125210

VL - 22

SP - 26

EP - 33

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -